UF Team Identifies Novel Targets for COVID-19 Antivirals
A multidisciplinary team of researchers at the University of Florida is making progress in their search for targets that could be used for developing treatments for infections with COVID-19. The team posted a paper to bioRxiv reporting the identification of 53 novel genes and pathways that could become druggable targets for antiviral therapies for COVID-19 plus a broad array of coronavirus types.
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it has entered into a licensing agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.
‘A Year of Change’: UF Reflects on COVID-19 Milestones
The University of Florida is reflecting back on the milestones made in the last year through the COVID-19 pandemic. From the initial lockdown in March 2020 to the rollout of vaccines in December, reflecting back on the year of change helps us see just how far we’ve come.
Patients With Severe COVID-19 Twice As Likely To Require Future Hospitalizations for Other Illnesses
People who have recovered from a bout of severe COVID-19 may still have a reason for concern about their health. A new University of Florida study has found that patients who had a severe case of the disease were more than twice as likely as patients who had mild or moderate COVID-19 to need hospitalization again for health problems caused by COVID-19 complications.
Mental Confusion, Disorientation May Be Early Warning Sign of Severe COVID-19
A new University of Florida study finds that patients with COVID-19 who displayed symptoms of disorientation and confusion were three times more likely to go on to develop severe COVID-19 than patients with the virus who did not experience neurological symptoms.
UF Health Researchers Join Global Effort To Track COVID-19 Pandemic and Others in Future
University of Florida Health researchers are joining an ambitious global effort led by The Rockefeller Foundation to better track the coronavirus and its variants and set up a network of collaborators to stop any nascent pandemic in the future.
COVID-19 Testing Method Gives Results Within 1 Second
Researchers from the University of Florida and Taiwan’s National Chiao Tung University have developed a rapid and sensitive testing method for COVID-19 biomarkers. Their findings were recently published in the Journal of Vacuum Science & Technology B.
Battling COVID-19 With Smart Wearables
Dr. Swarup Bhunia, director and the Semmoto Endowed Professor at University of Florida's Electric and Computer Engineering Department, and Dr. My T. Thai, associate director and UF's Research Foundation professor at the Computer and Information Science Engineering Department, share the different Covid-19 innovations coming out of the Warren B. Nelms Institute for the Connected World.
UF Health Researcher Explains Herd Immunity and How It Could End COVID-19 Pandemic
Cindy A. Prins, Ph.D., M.P.H., a University of Florida Health infectious disease epidemiologist who is an associate professor in the UF College of Public Health and Health Professions and the UF College of Medicine, looks at herd immunity and explains how it might be part of the answer.
DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants
UF Innovate | Sid Martin Biotech alum DiaCarta Inc. announced the publication of a study to rapidly detect new COVID-19 variants in MedRxiV.
